No association between polymorphism MNS16A in the telomerase catalytic subunit gene (hTERT) and breast cancer in Ardabil, Iran by شفیقی, شقایق et al.
Available online at www.ijmrhs.com 
 
 
Special Issue 9S: Medical Science and Healthcare: Current Scenario and Future Development 
 
 
 
ISSN No: 2319-5886 
 
 
 
International Journal of Medical Research & 
Health Sciences, 2016, 5, 9S:563-569 
 
 
 
563 
No association between polymorphism MNS16A in the telomerase catalytic subunit gene 
(hTERT) and breast cancer in Ardabil, Iran 
 
Shaghayegh Shafighi1, Roya Osoli2, Ebrahim Vosoughi3, Iraj Feizi4, Alireza Khalili5  
and S Saied Hosseini-Asl6* 
 
1Master in Genetics, Azad University, Ahar Branch 
2Medical Genetics lab., Imam Hospital, Department of Genetics, Ardabil University of Medical Sciences, Ardabil, 
Iran 
3Azerbaijan National Academy of Sciences, Genetic Resources Institute, Baku, Azerbaijan 
4Associate professor, Department of Surgery, Ardabil University of Medical Sciences, Ardabil, Iran 
5Pathologist, Imam Hospital, Ardabil University of Medical Sciences, Ardabil, Iran 
6Medical Genetics lab., Imam Hospital, Department of Genetics, Ardabil University of Medical Sciences, Ardabil, 
Iran 
*Corresponding Email: saied.hosseiniasl@arums.ac.ir 
_____________________________________________________________________________________________ 
 
ABSTRACT 
 
Breast cancer is the most frequent malignancy among women and its mortality is estimated to be about 519,000 
deaths per year. The telomerase activity seems to be necessary for the immortality of tumor cells. The association 
between telomerase reactivation and its catalytic subunit's (hTERT) expression has been reported in several studies. 
The length polymorphism MNS16A in the hTERT gene's promoter has been recognized to be associated with its 
expression status. The aim of this study was assaying the role of this polymorphism in conferring susceptibility of 
gaining breast cancer in women of Ardabil. Among the women affected with breast cancer in Ardabil, 53 paraffin 
embedded tumor samples were selected. Fifty-one persons with any positive history of cancer in them and their 1st 
and 2nd degree of relatives have been selected as control group. After DNA extraction by phenol-chloroform based 
method, the presence of variants of the polymorphism MNS16A was detected by PCR method. The alleles lengthen 
302 and 333 bp were nominated as L [Long] allele and S [Short] allele was referred to fragments with 243 and 272 
bp lengths. Data was analyzed by statistical methods and P value less than 0.05 was determined as significant 
difference. The frequency of genotypes SS, SL, and LL among cases were 56.6%, 18.86%, and 24.52%, respectively, 
and were 50.98%, 24.49%, and 21.56% for genotypes SS, SL, and LL among control group. Any significant 
relationship was detected between cases and control groups [P>0.05]. In this investigation, it was revealed that the 
noted polymorphism seems not to be a susceptibility factor for gaining breast cancer in Ardabil province. 
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INTRODUCTION 
 
Breast cancer is the most frequent malignancy among women with the worldwide death rate of 519,000 per year [1]. 
Previous studies on Iranian women  showed breast cancer in 17 out of 100,000 women with high incidence aging  45 
to 54 years old [2,3]. They revealed that 15-30% of women who are suffering breast cancer had a family history of 
breast or ovarian cancers. Studies on the impact of genetic and non-genetic factors and family studies associated 
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with early onset of disease have shown that breast cancer follows dominant traits. Genetic susceptibility against 
breast cancer emerges by accumulation of various mutations in some critical genes such as tumor suppressors and 
the genes involving in DNA repair., These alterations lead uncontrolled cell division, survival, proliferation, and 
tumor invasion[3,14,26]. 
 
Cancer incidence and mortality rates vary by race and geographic location. North Europe, North America, the 
Mediterranean and South American populations indicates higher, and Asian and Africans showed lowest incidence 
of breast cancer [4]. 
 
Telomerase is a DNA polymerase enzyme that is responsible to build a six-nucleotide replications (TTAGGG) at the 
ends of chromosomes to form a telomere structure. It creates caps at the end of chromosomes that prevent from the 
destruction and those annexations.[5,21,23,25] 
 
Since the DNA polymerase basically is unable to replicate the complete chromosome, so in each replication of 50 to 
100 nucleotides, shortening of chromosomes occurs which leads to aging the cell [5,12,21].      
 
In embryonic cells as well as some somatic cells, telomerase is responsible to restore telomeres length[6,15]. About 
90% of malignant cells show telomerase hyper-activation thus consequences  unlimited cell division and 
immortality [5,18, 22]. 
 
Human telomerase enzyme activity is composed of the human telomerase reverse transcriptase (hTERT), human 
telomerase RNA (hTR) and Dyskryn [6,17,19,27,28]. 
 
Several recent studies have provided evidence that polymorphisms in the telomerase reverse transcriptase [TERT] 
gene sequence are associated with cancer development, but a comprehensive synopsis is not 
available[6,16,20,29,30]. 
 
hTERT is located at chromosome 5p15.33 and has 16 exons[6,16]. 
 
Importance of a functional polymorphism of repetitive minisatellite  in hTERT gene which is called MNS16A in 
cancer incidence has been shown previously [7,8,10].  
 
In 2003, Wang et al. first reported in a lung cancer study the identification of a polymorphic tandem repeats 
minisatellite  hTERT termed MNS16A[7] . 
 
This minisatellite is located down-stream of exon 16 of hTERT gene and up-stream in the putative promoter.[8] 
 
MNS16Awas found to have two repeat elements forming a 23 bp core sequence or a 26 bp core sequence with a 
CAT insertion representing a transcription factor binding site for GATA-1. Two different variable number of 
tandem repeats [VNTR alleles, VNTR-302 and VNTR-243 were named on basis of their polymerase chain reaction 
[PCR] fragment size. In addition, two other rare alleles [VNTR-272 and VNTR-333] were discovered in cancer cell 
lines. For statistical analysis, a classification in short alleles [S alleles: VNTR-243 and VNTR-272] and long alleles 
[L alleles: VNTR-302 and VNTR-333] was introduced by Wang et al. [8]. Region of an antisense hTERT transcript 
MNS16A position is as a polymorphism that is classified as a long or short position.[7,8] 
 
Numerous studies on gene expression of hTERT revealed that MNS16A alteration on hTERT gene was associated 
with its increased transcription and promotor activity [8] as far as it has been considered as a potential marker for 
glioblastoma [9], breast [10] and lung [11] cancers.  
 
The aim of this study was to investigate the possible relationship of hTERT MNS16A polymorphism and breast 
cancer risk in the women population of Ardebil province, Northwestern Iran. 
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MATERIALS AND METHODS 
 
Sampling 
53 paraffin-embedded breast tumor samples and 51 normal  Breast tissue  samples obtained from the pathology 
laboratories at Ardabil University of Medical Sciences  Imam Khomeini Hospital were participated. 
All patients signed detailed consent forms before the study was conducted. 
 
The experimental samples were pre-made on standard slides with 5 micron thick FFPE tissues using the standard 
method by the Department of Pathology, Imam Hospital. 3-5 slices of 5 micron from selected samples placed in the 
1.5 ml micro- tube and DNA samples were extracted with phenol-chloroform manually with using xylol, ethanol, 
Layzyz buffer, proteinase K, phenol saturated, chloroform - isoamyl alcohol, sodium acetate, isopropanol and the 
finally 50 micro- liter of distilled water added. 
 
DNA fragment analysis 
Paraffin removal from paraffin-embedded samples was done by xylene solution, . Genomic DNA was extracted 
using phenol-chloroform standard procedure. DNA quality was measured by a spectrophotometer Nanodrop, and a 
mixture of 20 microliter for each sample was prepared. Polymerase chain reaction [PCR] was performed to 
amplification of target DNA using specific oligonucleotide primers. 
 
PCR protocol was as follow: 
10 ml  of PCR reaction mixture,  plus 1 ml  of the primer mixtures [forward; 
AGGATTCTGATCTCTGAAGGGTG-`3, reverse; 5`- TCTGCCTGAGGAAGGACGTATG -3], 16 ml Taq DNA 
polymerase enzyme [5 µL/U] and 3 ml  of genomic DNA were mixed in a 0.2 ml micro-tubes. 
 
DNA denaturation took place at 95 °C for 30 seconds, annealing was done at 55 ° C for 45 minutes and elongation 
was performed  at 72 °C for 1 minute. All PCR reaction was done in 35 cycles. Final elongation step was taken 10 
minutes at 72 °C. PCR product was analyzed by agarose gel electrophoresis. 
 
According to previous researches, four alleles of MNS16A were identified and they were divided into L long allele 
[333 and 302 bp] and S short alleles [272 and 243 bp][7,8]. Differences in genotype distribution in two groups were 
studied. 
 
Data analysis  
Achieved non-parametric data were analyzed by using the SPSS v. 16 . applying Mann-Whitney test to compare 
frequency distribution of three different MNS16A genotypes in the hTERT gene, P <0.05 was considered as 
significant difference. The odds ration and confidence level for the dependent and independent variables were 
calculated as 95% interval. 
 
RESULTS 
 
All patients participating in the study were female and the mean age was 48.35± 1.3 [25-79] and control group mean 
age was 39.2± 1.03 [17-56]. 
 
 
 
Figure1. PCR result on electrophoresis gel 
 
The Mann-Whitney distribution of genotypes and alleles prevalence in patients and controls group with showed that 
the distributions of genotypes were not significantly different in two groups [P> 0.05]. 
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The SS, SL and LL polymorphism frequencies in the patients were 56.60. , 18.86 and 24.52 percent respectively. 
While, the ratios in the controls group were as 50.98, , 24.49 and 21.56 percent respectively. SS genotype frequency 
in addition to SL in patient group was observed as 75.47%  whereas in the control group it was 76.47% [Table 1]. In 
both patients and control groups, SS genotype percentage was high. 
 
Also no correlation was found between the frequency of genotypes and S and l alleles with breast cancer [P> 0.05]. 
 
Table1 :Investigated geneotype and allele frequencies in MNS16A gene in the studied breast cancer cases and healthy controls 
 
 
SS SL LL SL S L 
Cases 
]53[ 
30 
]56.6%[ 
10 
]18.9%[ 
13 
]24.5%[  
40 
]75.5%[ 66% 34% 
Controls 
]51[ 
26   
]51%[ 
13 
]49.2%[ 
12 
]23.5%[ 
39 
]76.5%[ 63.7% 36.3% 
 
In addition, the relationship between SS + SL and LL of MNS16A in hTERT gene with cancer stages [TNM], tumor 
grade [Figure 2], ALN [metastasis] [Figure 3] and patients' ages [Figure 4] were studied and no significant 
correlation was found. 
 
Figure2. The relationship between MNS16A genotypes in hTERT gene and tumor grade  
S Saied Hosseini-Asl et al Int J Med Res Health Sci. 2016, 5(9S):563-569 
______________________________________________________________________________ 
567 
 
Figure 3: The relationship between MNS16A genotypes in hTERT gene and  metastasis [ALN] 
 
 
Figure 4: The relationship between MNS16A genotypes in hTERT gene and patients' ages 
 
DISCUSSION 
 
The previous studies suggest that factors such as genetic polymorphism may reflect individual differences in the 
incidence of cancer. Breast cancer is the leading cause of death among women in Western countries and molecular 
changes including hTERT gene polymorphism is associated with the development of the disease. MNS16A is a 
S Saied Hosseini-Asl et al Int J Med Res Health Sci. 2016, 5(9S):563-569 
______________________________________________________________________________ 
568 
functional mini satellite polymorphism with repetitions in hTERT gene which has been recognized as a molecular 
polymorphism in hTERT gene [11]. 
 
Breast cancer in three conducted studies showed that only in Chinese carrier with short alleles, the risk of breast 
cancer increases [10], while in two other studies on whites and Greek Caucasian women no change in the risk of 
breast cancer was reported. [12 ,13] 
 
This study did not  found any significant relationship between L and S alleles and susceptibility to breast cancer 
either, so the results of this study are consistent with Zagory and et. al  in 2012 on Greek Caucasian women [13] and 
also Chen and et al [ 2010] results [12], but the results of this study are different from the study of breast cancer 
among Chinese women in 2008 which was done by Wang and et al [2008] that positively support the relationship 
between MNS16A S allele of hTERT gene and increased risk of breast cancer and also invasive behavior is 
correlated with metastatic axillary lymph nodes [ 10]. 
 
Other studies show that racial background may have a significant impact on the genetic diversity of telomere and 
breast cancer. As new findings of breast cancer studies showed, apart from race, a certain texture is different from 
positive association with lung cancer[7], nasopharyngeal carcinoma[31], colorectal cancer[8] and malignant 
glioma[9]. It should be noted that probably there are some essential cofactors in specific functional tissues that needs 
to be explored in the future. In any case, Hardy-Weinberg inconsistency necessarily invalidates the results of an 
association study. 
CONCLUSION 
 
MNS16 A polymorphism of hTERT gene does not seem to be a risk factor for breast cancer among women in 
Ardabil province. However, in addition, other studies showed that this polymorphism as a special case needs to be 
examined more deeply. 
 
 As a result, it is suggested that this study be conducted on more individuals to determine whether previous studies 
that have reported a positive relationship, caused by ethnic differences or intervention factors. 
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